Recent developments in high- and low-energy particle beam-based production of actinoids and lanthanoids at TRIUMF

by Paul Schaffer (TRIUMF)

Thursday 17 Oct 2024, 11:00 → 12:00 Europe/Zurich

40/S2-C01 - Salle Curie (CERN)

Abstract: 

The Life Sciences Division at TRIUMF pursues both fundamental and applied research and development under three core pillars: studies and applications withions beams, nuclear chemistry, and the application of isotopes - all to understand life at the molecular level.

To achieve our goals, we rely on all accelerators at TRIUMF – from 13 to 520 MeV, including the nearly completed Advanced Rare Isotope Laboratory (ARIEL) electron linac, and the long running Isotope Separator and Accelerator (ISAC) facilities – all of which serve as drivers for research across our core study areas. Together with our radiochemistry and beta-NMR laboratories, the division maintains cutting-edge facilities and expertise in the research and development of radioisotopes and radiopharmaceuticals for use in nuclear medicine, radiotherapy, and the broader life sciences.

This seminar will discuss recent developments in producing and isolating actinoid and lanthanoid isotopes via high- and low-energy production routes, along with using ISAC-ISOL to isolate, then produce experimental radiopharmaceuticals for in vivo studies. 

ATS Seminar Organisers: A. Dallocchio (EN), E. Metral (BE), M. Modena (ATS-DO), T. Stora (SY)

attachment1729152528089.pdf